About Nevia Bio
Nevia Bio is a company based in Haifa (Israel) founded in 2023 by Inbal ZafirLavie, Roni Michaely, and Shlomit YehudaiReshef. Nevia Bio has raised $3.1 million across 1 funding round from investors including Technion - Israel Institute of Technology, MindUP and Pitango. Nevia Bio offers products and services including Machine Learning Platform, Vaginal Swab Test, Nevia-001, and Nevia-002. Nevia Bio operates in a competitive market with competitors including Ovia Health, Moody Month, Panakeia, Boston Medical Sciences and Syrona Health, among others.
- Headquarter Haifa, Israel
- Founders Inbal ZafirLavie, Roni Michaely, Shlomit YehudaiReshef
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.1 M (USD)
in 1 rounds
-
Latest Funding Round
$3.1 M (USD), Seed
Aug 29, 2023
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nevia Bio
Nevia Bio offers a comprehensive portfolio of products and services, including Machine Learning Platform, Vaginal Swab Test, Nevia-001, and Nevia-002.
AI platform for analyzing vaginal secretions to detect diseases early
Simple tool for sample collection in women's health screening
Pipeline program targeting ovarian cancer detection
Pipeline program for endometriosis detection
Funding Insights of Nevia Bio
Nevia Bio has successfully raised a total of $3.1M through 1 strategic funding round. The most recent funding activity was a Seed round of $3.1 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nevia Bio
Nevia Bio has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Technion - Israel Institute of Technology, MindUP and Pitango.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
MindUP is recognized as Israel’s digital health incubator.
|
Locked | Locked | Locked | |
|
Venture capital investments in tech and healthtech sectors through dedicated funds.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Nevia Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nevia Bio
Investment portfolio details for Nevia Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nevia Bio
Detailed financials for Nevia Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nevia Bio Comparisons
Peer comparison for Nevia Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nevia Bio
Nevia Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ovia Health, Moody Month, Panakeia, Boston Medical Sciences and Syrona Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Mobile applications for women's and family health are provided.
|
|
| Locked | Locked | Locked |
Daily wellness solutions for women are provided by Moody Month.
|
|
| Locked | Locked | Locked |
AI-based software is provided for cancer diagnosis and precision treatment.
|
|
| Locked | Locked | Locked |
AI-powered colorectal cancer screening system
|
|
| Locked | Locked | Locked |
Digital women's health management software for employers and individuals
|
|
| Locked | Locked | Locked |
Provider of menstrual cycle and pregnancy monitoring software for women
|
Detailed competitors of Nevia Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nevia Bio
Complete news archive for Nevia Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nevia Bio
Nevia Bio was founded in 2023.
Nevia Bio is headquartered in Haifa, Israel. It is registered at Haifa, Haifa District, Israel.
Inbal ZafirLavie is the current CEO of Nevia Bio. They have also founded this company.
Nevia Bio is a funded company, having raised a total of $3.1M across 1 funding round to date.
Nevia Bio was founded in 2023 in Haifa, Israel, within the health technology sector. A platform powered by machine learning is operated to detect women-related diseases early through analysis of vaginal secretions. Proprietary technologies are applied for identification, including ovarian cancer cases. Development programs currently include Nevia 001, Nevia 002, and Nevia 003, focusing on diagnostic advancements.
Nevia Bio's top competitors include Ovia Health, Syrona Health and Panakeia.
Nevia Bio offers Machine Learning Platform, Vaginal Swab Test, Nevia-001, and Nevia-002.
Nevia Bio has 4 investors. Key investors include Technion - Israel Institute of Technology, MindUP, Pitango, and ALIVE.